Inventor

LAWRENCE RONNIE MAXWELL

GB14 patents

⚠️ This page may combine multiple inventors who share the name “LAWRENCE RONNIE MAXWELL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ORPHALAN S A

5 patents

US11117855B2Sep 14, 2021

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

ORPHALAN S A4 citations80

US11072577B2Jul 27, 2021

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

ORPHALAN S A6 citations80

US10988436B2Apr 27, 2021

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

ORPHALAN S A6 citations80

US12358862B2Jul 15, 2025

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

ORPHALAN S A0 citations59

US12358861B2Jul 15, 2025

Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use

ORPHALAN S A0 citations59

SMITHKLINE BEECHAM CORP

2 patents

US6548523B2Apr 15, 2003

Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties

SMITHKLINE BEECHAM CORP17 citations83

US7425639B2Sep 16, 2008

Process

SMITHKLINE BEECHAM CORP15 citations80

KING S COLLEGE LONDON

2 patents

US11584741B2Feb 21, 2023

Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation

KING S COLLEGE LONDON0 citations58

US10870644B2Dec 22, 2020

Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation

KING S COLLEGE LONDON1 citations56

GLAXOSMITHKLINE LLC

1 patent

US7709677B2May 4, 2010

Process of preparing arylethanoldiamines

GLAXOSMITHKLINE LLC14 citations80

CRAIG ANDREW SIMON

1 patent

US8796269B2Aug 5, 2014

Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same

CRAIG ANDREW SIMON11 citations73

ANDERTON CLARE LOUISE

1 patent

US8093242B2Jan 10, 2012

Crystalline forms of a pyridine derivative

ANDERTON CLARE LOUISE8 citations73

GLAXO GROUP LTD

1 patent

US7557209B2Jul 7, 2009

Process for the preparation of (1S,4R)-cis-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol

GLAXO GROUP LTD2 citations61

ACTIMED THERAPEUTICS LTD

1 patent

US12109192B2Oct 8, 2024

Organic acid addition salts of S-pindolol

ACTIMED THERAPEUTICS LTD0 citations51